Scott Grisanti has been named president/CEO of Aduromed Industries (Bethel, Connecticut), a provider of technology and services for the onsite treatment and disposal of regulated medical waste. Grisanti previously was executive vice president of sales, marketing and services at Primavera Systems, a provider of program and portfolio management application software and services solutions used to manage large capital projects in targeted market segments.

Philip Theodore has been named vice president, compliance, legal and corporate development for BioReliance (Rockville, Maryland), a contract services company that provides biologics safety testing, toxicology, viral manufacturing and laboratory animal diagnostic services to the pharmaceutical and biopharmaceutical industries worldwide. He previously was a partner with the law firm of King & Spalding, where he was a member of the mergers and acquisitions practice group. He also served as vice president/general counsel of Serologicals from 2004 until the company was sold in 2006.

Ronald Allen has been named to the board of directors of Guided Therapeutics (Norcross, Georgia). He is a former chairman/president/CEO of Delta Air Lines. Guided Therapeutics is developing a rapid and painless test for the early detection of disease that leads to cervical cancer.

William Arthur III has been named vice president of business development at Insulet (Bedford, Massachusetts), a developer of patch pump technology with its OmniPod Insulin Management System. Arthur previously was president/COO of SpectRx, where he oversaw the design, manufacture and marketing of the company's insulin pump infusion set disposables.

Randall H. H. Madry has been named executive director of the National Coalition for Quality Colorectal Cancer Screening and Care (Annapolis, Maryland). Madry has served as deputy commissioner for the North Carolina Department of Insurance. He has chaired the National Association of Insurance Commissioner's Health Plan Accountability Work Group and served as president/CEO of URAC, the American Accreditation Health Care Commission, an accreditation agency promoting quality standards and practices in healthcare.

Fabio Trave, MD has been named executive director of medical affairs and strategic product development for Premier Research Group (Philadelphia), an international pharmaceutical services company. Premier said Tave will strengthen its capabilities in the area of drug development consulting and the oncology therapeutic area. He will be based in the company's Milan, Italy, office. He has worked for both North American and European-based pharmaceutical companies, most recently with Bristol Myers-Squibb, where he was responsible for pharmacovigilance activities in Europe, Middle East and Africa. Premier Research has 30 offices and operates in more than 30 countries across Europe and North America .

No Comments